Stay updated on Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to Neoadjuvant Combination Immunotherapy for Stage III Melanoma. This change may reflect an adjustment or new information regarding the clinical trial's progress or details.
    Difference
    0.2%
    Check dated 2024-06-06T14:46:23.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying inclusion and exclusion criteria for the study. Previously, this section had no information provided.
    Difference
    25%
    Check dated 2024-05-22T21:31:57.000Z thumbnail image
  8. Check
    39 days ago
    Change Detected
    Summary
    The value of the Primary Completion date has recently changed from 2026-06-01 to . This change likely indicates an update or revision in the estimated completion date for the medical study on Neoadjuvant Combination Immunotherapy for Stage III Melanoma.
    Difference
    0.1%
    Check dated 2024-05-04T09:52:02.000Z thumbnail image
  9. Check
    40 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 2022 07 19 2024 2027 2022 07 16 2022 07 19 2022 07 to 2024 05 02 2026 2028 2024 04 30 (Estimated) 2024 05 02 2024 04. This change likely reflects updated timelines or information related to the Neoadjuvant Combination Immunotherapy for Stage III Melanoma clinical trial, specifically regarding the study completion date and other relevant dates.
    Difference
    2%
    Check dated 2024-05-03T08:20:49.000Z thumbnail image
  10. Check
    43 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:43:34.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.